Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Crossover, Kinetic Study to Assess the Relative Bioavailability of Omega-3 Fatty Acids in Two Supplement Products in Healthy Adult Men and Women
Conditions
Interventions
EPA + DHA Ruby-O
EPA + DHA Krill Oil
Locations
1
United States
Health Awareness
Port Saint Lucie, Florida, United States
Start Date
July 11, 2022
Primary Completion Date
September 18, 2022
Completion Date
September 18, 2022
Last Updated
December 1, 2022
NCT07063173
NCT07345130
NCT07046975
NCT06882681
NCT06641245
NCT06177483
Lead Sponsor
Midwest Center for Metabolic and Cardiovascular Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions